Navigation Links
Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
Date:6/18/2008

New Development Programs to Include Response Prediction to Ovarian Cancer

Treatment, Predicting Risk of Gastric Cancer Recurrence, and

Differentiation of Small Cell From Non-Small Cell Lung Cancer In Addition, the Company has Identified Unique microRNA Biomarkers in the Serum of Colon Cancer Patients, Which may Serve as the Basis for a Future

Test for Colon Cancer New Tests Expected to be Developed and Marketed Through the Company's Clinical Laboratory Improvement Act (CLIA) Certified Laboratory, for Which

a Binding Acquisition Term Sheet has Recently Been Signed

REHOVOT, Israel and JERSEY CITY, New Jersey, June 18 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (Nasdaq: ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced today the advancement of three new diagnostic tests into its development pipeline. The Company expects to develop and market the new tests through its own CLIA-certified laboratory, for which the Company recently signed a binding acquisition term sheet.

"We aim to be the leading high-complexity molecular diagnostics company, and we believe we have fine-tuned our product engine. This engine is now capable of producing a stream of products that answer unmet medical needs," said Amir Avniel, CEO and President of Rosetta Genomics. "We believe that by the end of 2009, we will have established a prominent position in the oncology and women's health fields."

Leveraging unique microRNA biomarkers identified using Rosetta Genomics' proprietary microRNA extraction and quantification methods, the new programs will focus on the following indications, which are expected to be clinically available during 2009-201
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Cambridge Semantics ... last week’s “Data Demonstration Day” on Capitol Hill, hosted by ... EMC, Google, Microsoft and others to showcase how innovative data ... Accountability and Transparency Act (DATA Act). , Originally introduced in ... (R-CA) and Sen. Mark Warner (D-VA ), ...
(Date:5/22/2013)... ORLEANS , May 22, 2013  Organogenesis Inc., ... presented new data generated in collaboration with a team ... economics consultancy) demonstrating the significant healthcare resource and economic ... ulcers (VLU) place upon the US healthcare system. ... annual costs of up to $15 billion and $18 ...
(Date:5/22/2013)... 22, 2013 Express Diagnostics Int’l, ... Ltd are pleased to announce a sponsorship agreement ... and New Zealand distributor of DrugCheck® onsite testing devices, ... participated in the Austin 400 May 17-19 in Austin, ... agreement that involves each car of the Erebus Motorsport ...
(Date:5/22/2013)... CAMBRIDGE, Mass. , May 22, 2013  Moderna ... revolutionary new treatment modality to enable the in ... John Reynders will join Moderna ... Reynders is a proven leader in ... phases of drug development, from discovery to translation, clinical ...
Breaking Biology Technology:Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3
... MELVILLE, N.Y., Sept. 12 Fougera, a division ... approved its Clotrimazole Cream USP,1%. The generic formulation ... available in three sizes: 15g tubes (NDC # ... (NDC # 0168-0133-46)., "The approval of Clotrimazole ...
... YORK, Sept. 12 Exosome Diagnostics, Inc. today,announced ... of genetics,research. In this role, Dr. Skog will ... of its blood-based diagnostics that can,identify cancer-specific genetic ... and inventor of Exosome Diagnostics,core technology that has ...
... Acologix, Inc., a privately,held biopharmaceutical company, today ... AC-100, its therapeutic product,candidate derived from an endogenous ... cartilage regeneration in large animal models. The,data will ... September,13, 2008 at the 30th ASBMR (American Society ...
Cached Biology Technology:Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting 2Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting 3
(Date:5/21/2013)... American Chemical Society (ACS), the world,s largest scientific ... National Meeting & Exposition, September 8-12, 2013, in ... Indiana Convention Center and at area hotels. , ... that span science,s horizons from astronomy to ... and online journalists a rich assortment of spot ...
(Date:5/21/2013)... epigenetic modifications, which alter the way genes function ... be detected in the blood of pregnant women ... to foretell depression in the weeks after giving ... become debilitating. , The findings of the small ... in the journal Molecular Psychiatry . , ...
(Date:5/20/2013)... compound abundant in the Mediterranean diet takes away cancer ... a very specific step in gene regulation, this compound ... as scheduled. , One way that cancer cells thrive ... to die on a regular cycle that is subject ... Ohio State University researchers, found that a compound in ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
... enables rice to survive complete submergence has beenidentified ... RiceResearch Institute in the Philippines and at the ... allows fordevelopment of new rice varieties that can ... and offering reliefto millions of poor rice farmers ...
... have invaded, they usually find predictable patterns. The diversity ... processes such as nutrient cycling, wildfire frequency and the ... simply observing such changes doesn't prove that the invaders ... Farrer and Deborah Goldberg, however, came up with a ...
... time in as many months, the IODP Arctic Coring Expedition ... In the Aug. 10 issue of Nature, an article by ... that the Arctic was extremely warm, unusually wet, and ice-free ... gases were released into the Earth's atmosphere ?a period calculated ...
Cached Biology News:New flood-tolerant rice offers relief for world's poorest farmers 2New flood-tolerant rice offers relief for world's poorest farmers 3Invasive species alter habitat to their benefit 2Invasive species alter habitat to their benefit 3Arctic coring expedition continues to yield new clues 2
2 ml SmartScan Racks...
Leptin Receptor Polyclonal Ab 100 ug purified rabbit anti-mouse Leptin Receptor. Tested in Western blotting....
... a compact, highly versatile power supply. Capable of ... this power supply is ideal for PAGE, SDS-PAGE, ... all types of small format transfer apparatus. It ... constant current with a continuously variable output in ...
... PLAU N-term Antibody This antibody is generated ... synthetic peptide selected within aa 50~150 of ... in PBS with 0.09% (W/V) sodium azide. ... G column and eluted out with both ...
Biology Products: